Determinants of Efficacy of EsophyX Treatment in Gastro-Esophageal Reflux Disease
Recruitment status was Recruiting
EsophyX is a promising endoscopic treatment for gastro-esophageal reflux disease. It is not known whether there are some pre- or per-operative anatomic or pathophysiological findings which may influence outcome.
The aim of this trial is to study a series of parameters acquired during the pre-therapeutic work-up or during the procedure and their influence on the outcome of the procedure.
Gastroesophageal Reflux Disease
|Study Design:||Time Perspective: Longitudinal|
|Official Title:||Determinants of Efficacy of EsophyX Treatment in Gastro-Esophageal Reflux Disease|
Please refer to this study by its ClinicalTrials.gov identifier: NCT00498082
|Contact: Hubert Piessevaux, MD, PhD||+ 32 2 764 28 email@example.com|
|Cliniques universitaires St-Luc||Recruiting|
|Brussels, Belgium, 1200|
|Principal Investigator: Hubert Piessevaux, MD, PhD|
|Principal Investigator:||Hubert Piessevaux, MD, PhD||Cliniques universitaires St-Luc|